The Online Investor

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Fri., Feb. 22, 2:43 AM

Slide #1. Arlington Asset Investment Corp. Secondary Offering

Company: Arlington Asset Investment Corp. (NYSE:AI)
Date announced: 2/19/2019
Shares Offered: 6,000,000
Date of Pricing: 2/19/2019
Price Per Share: $8.33
Secondary Offering Details: Arlington Asset Investment Corp. (NYSE: AI) (the "Company") announced today that it has commenced an underwritten registered public offering of 6,000,000 shares of Class A common stock. The Company also expects to grant the underwriters an option for 30 days to purchase up to an additional 900,000 shares of Class A common stock. Morgan Stanley & Co. LLC and JMP Securities LLC will serve as joint book running managers for the offering. The underwriters propose to offer the shares of Class A common stock for sale from time to time in one or more negotiated transactions or otherwise, at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices. -updated 2/19- Arlington Asset Investment Corp. (NYSE: AI) (the "Company") announced today that it has priced an underwritten registered public offering of 6,000,000 shares of Class A common stock resulting in expected gross proceeds of approximately $50.0 million, before deducting underwriting discounts and estimated offering expenses. The Company has granted the underwriters an option for 30 days to purchase up to an additional 900,000 shares of Class A common stock. Morgan Stanley & Co. LLC and JMP Securities LLC are serving as joint book running managers for the offering. JonesTrading Institutional Services LLC is serving as co-manager for the offering. The underwriters propose to offer the shares of Class A common stock for sale from time to time in one or more negotiated transactions or otherwise, at market prices prevailing at the time of sale, at prices related to such prevailing market prices or at negotiated prices. The offering is subject to customary closing conditions and is expected to close on Friday, February 22, 2019.

Arlington Asset Investment is an investment firm that focuses on acquiring and holding a levered portfolio of residential mortgage-backed securities (MBS), consisting of agency MBS and private-label MBS. Agency MBS include residential mortgage pass-through certificates for which the principal and interest payments are guaranteed by the U.S. government agency or government sponsored enterprise (GSE), such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation. Private-label MBS include residential MBS that are not guaranteed by a GSE or the U.S. government. As of Dec 31 2017, nearly all of Co.'s investment capital was allocated to agency MBS.

AI SEC Filing Email Alerts Service

Preferred: AI.PRB


Open the AI Page at The Online Investor »

Company Name: 
Arlington Asset Investment Corp
Website: 
www.arlingtonasset.com
Sector: 
Credit Services & Lending
Number of ETFs Holding AI: 
16
Total Market Value Held by ETFs: 
$10.96M
Total Market Capitalization: 
$248.00M
% of Market Cap. Held by ETFs: 
4.42%
 

Open the AI Page at The Online Investor (in a new window) »

List of Secondary Stock Offerings in this Slideshow:

1/28/2019:
Company: Pulmatrix, Inc. (PULM)
Shares Offered: 1,561,177
More: offering details »

1/28/2019:
Company: MGM Growth Properties LLC (MGP)
Shares Offered: 14,500,000
More: offering details »

1/28/2019:
Company: FNCB Bancorp, Inc. (FNCB)
Shares Offered: 2,857,000
More: offering details »

1/29/2019:
Company: Redwood Trust, Inc. (RWT)
Shares Offered: 10,000,000
More: offering details »

1/29/2019:
Company: First Hawaiian, Inc. (FHB)
Shares Offered: 24,900,000
More: offering details »

1/30/2019:
Company: Pulmatrix, Inc. (PULM)
Shares Offered: 5,323,530
More: offering details »

1/30/2019:
Company: Atrium Mortgage Investment Corporation (AI.CA)
Shares Offered: 2,300,000
More: offering details »

1/31/2019:
Company: Kiniksa Pharmaceuticals, Ltd. (KNSA)
Shares Offered: 2,654,984
More: offering details »

2/4/2019:
Company: Invesco Mortgage Capital Inc. (IVR)
Shares Offered: 14,000,000
More: offering details »

2/5/2019:
Company: Aeglea BioTherapeutics, Inc. (AGLE)
Shares Offered: 3,750,000
More: offering details »

2/7/2019:
Company: OncoCyte Corporation (OCX)
Shares Offered: 9,333,334
More: offering details »

2/7/2019:
Company: Presidio, Inc. (PSDO)
Shares Offered: 4,000,000
More: offering details »

2/8/2019:
Company: Staffing 360 Solutions, Inc. (STAF)
Shares Offered: 2,425,000
More: offering details »

2/8/2019:
Company: Pinduoduo Inc. (PDD)
Shares Offered: 40,185,000
More: offering details »

2/11/2019:
Company: Xeris Pharmaceuticals, Inc. (XERS)
Shares Offered: 5,000,000
More: offering details »

2/12/2019:
Company: MacroGenics, Inc. (MGNX)
Shares Offered: 5,500,000
More: offering details »

2/14/2019:
Company: Achaogen, Inc. (AKAO)
Shares Offered: 15,000,000
More: offering details »

2/14/2019:
Company: Reed's Inc. (REED)
Shares Offered: 6,725,000
More: offering details »

2/14/2019:
Company: American Resources Corp. (AREC)
Shares Offered: 1,000,000
More: offering details »

2/15/2019:
Company: Killam Apartment REIT (KMP.UN.CA)
Shares Offered: 4,390,000
More: offering details »

2/19/2019:
Company: Ovid Therapeutics Inc. (OVID)
Shares Offered: 12,500,000
More: offering details »

2/19/2019:
Company: Ovid Therapeutics Inc. (OVID)
Shares Offered: 2,500
More: offering details »

2/19/2019:
Company: ARMOUR Residential REIT, Inc. (ARR)
Shares Offered: 6,000,000
More: offering details »

2/19/2019:
Company: Sienna Biopharmaceuticals, Inc. (SNNA)
Shares Offered: 8,000,000
More: offering details »

2/19/2019:
Company: Arlington Asset Investment Corp. (AI)
Shares Offered: 6,000,000
More: offering details »

Quotes delayed 20 minutes



Buy (3.00 out of 4)
41st percentile
(ranked lower than approx. 59% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.